CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy. - Fontana M; Solomon SD; Kachadourian J; Walsh L; Rocha R; Lebwohl D; Smith D; Täubel J; Gane EJ; Pilebro B; Adams D; Razvi Y; et al. (The New England journal of medicine, 2024)